Cisplatin and S-1 for urachal carcinoma: A single-institution case series.
Tetsuya UrasakiYoichi NaitoNobuaki MatsubaraMasaoki SasakiTakahiro KogawaAko HosonoPublished in: IJU case reports (2019)
The activity of cisplatin and S-1 is modest and more efficacious treatment is desired against urachal carcinoma.
Keyphrases